| 产品详情 |
| Edit |   |
| Product Name | p38 MAP Kinase Inhibitor XIX, Skepinone-L |
| Description | Purity ~99% (HPLC). A cell-permeable phenylamino-dibenzosuberone-diol with a rigid molecular structure specifically designed to target hydrophobic region I in p38alpha & p38beta, but not in other kinases with bulky entrance-blocking gatekeeper residues. Shown to selectively inhibit p38alpha (IC50 = 5nM; [ATP] = 100uM) and p38beta (97% inhibition at 1uM), while exhibiting little affinity toward 400 other kinase constructs, including p38delta, p38upsilon, Erk1/2/3/4/5/8, JNK1/2/3, and MEK1/2/3/4/6. Shown to prevent cellular HSP27 Ser82 phosphorylation upon p38 activation by Anisomycin in HeLa (IC50 = 25nM) or by TNF-alpha in THP-1 cultures. Unlike the ATP-binding site-targeting BIRB 796 and SB 203580, Skepinone-L does not inhibit JNK-mediated c-Jun or ERK-dependent CREB phosphorylation in THP-1 cultures. Oral administration to D-Gal-sensitized mice is reported to greatly reduce plasma TNF-alpha production upon LPS challenge (by 77%; 3mg/kg p.o.) in vivo. Formula: C24H21F2NO4 Solubility: |
| Size | 5mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | p38 MAP Kinase Inhibitor XIX, Skepinone-L ((2-(2,4-Difluorophenylamino)-7-[2R-,3-dihydroxypropoxy]-10,11-dihydro-dibenzo[a,d]-cyclohepten-5-one)) |
| Gene, Accession, CAS # | n/a |
| Catalog # | 217619 |
| Price | |
| Order / More Info | p38 MAP Kinase Inhibitor XIX, Skepinone-L from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|